{"DataElement":{"publicId":"7072153","version":"1","preferredName":"Oral Route of Administration Contrast Agent Administered Dose","preferredDefinition":"The amount of oral contrast agent administered for an imaging procedure.","longName":"AGCONTDS","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"7071865","version":"1","preferredName":"Procedure Agents Domain Oral Route of Administration Contrast Agent Administered","preferredDefinition":"A domain utilized for the submission of information encompassing and representing data, vocabulary or records related to agents used as part of a procedure._The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins._Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue._The act of having given something (e.g., a medication or test).","longName":"6663252v1.0:7071863v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6663252","version":"1","preferredName":"Procedure Agents Domain","preferredDefinition":"A domain utilized for the submission of information encompassing and representing data, vocabulary or records related to agents used as part of a procedure.","longName":"C117755","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Procedure Agents Domain","conceptCode":"C117755","definition":"A domain utilized for the submission of information encompassing and representing data, vocabulary or records related to agents used as part of a procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8394B60A-D64E-39C1-E053-F662850A000B","latestVersionIndicator":"Yes","beginDate":"2019-03-08","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-03-08","modifiedBy":"ONEDATA","dateModified":"2019-03-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7071863","version":"1","preferredName":"Oral Route of Administration Contrast Agent Administered","preferredDefinition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.:Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.:The act of having given something (e.g., a medication or test).","longName":"C38288:C390:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Oral Route of Administration","conceptCode":"C38288","definition":"The introduction of a substance to the mouth or into the gastrointestinal tract by the way of the mouth, usually for systemic action. It is the most common, convenient, and usually the safest and least expensive route of drug administration, but it uses the most complicated pathway to the tissues and bioavailability varies. The disadvantages of method are hepatic first pass metabolism and enzymatic degradation of the drug within the gastrointestinal tract. This prohibits oral administration of certain classes of drugs especially peptides and proteins.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Contrast Agent","conceptCode":"C390","definition":"Substances administered during imaging procedures that allows delineation of internal structures. Contrast agents appear opaque due to the difference in absorption of X-rays or other electromagnetic waves and surrounding tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"990119E2-974F-4A59-E053-F662850ADEF0","latestVersionIndicator":"Yes","beginDate":"2019-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-05","modifiedBy":"ONEDATA","dateModified":"2019-12-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"990119E2-9760-4A59-E053-F662850ADEF0","latestVersionIndicator":"Yes","beginDate":"2019-12-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-05","modifiedBy":"KUMMEROA","dateModified":"2020-06-11","changeDescription":"Released. AK 2020-6-11 Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6400566","version":"1","preferredName":"CDISC Variable Terminology Dose","preferredDefinition":"The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables._A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"CDISCDOS","context":"NCI Standards","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6400565","version":"1","preferredName":"CDISC Variable Terminology Dose","preferredDefinition":"The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables.:A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","longName":"C83187:C25488","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CDISC Variable Terminology","conceptCode":"C83187","definition":"The terminology subset that includes terms relevant to the Clinical Data Interchange Standards Consortium (CDISC) variables.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"736B7AB9-91D0-713C-E053-F662850A6B6D","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-14","modifiedBy":"ONEDATA","dateModified":"2018-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"736B7AB9-91E1-713C-E053-F662850A6B6D","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-14","modifiedBy":"KUMMEROA","dateModified":"2021-06-09","changeDescription":"Elevated to Standard per governance approval by RA. 2021-6-9 ak .11-19-18 TT added max length. 8-14-18 Created as part of the CDISC mapping task; tt.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318324","version":"1","longName":"CT Image - CDISC Aligned ","context":"NCI Standards"},{"publicId":"7318326","version":"1","longName":"CT Image Agent - CDISC Aligned","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 3908103 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"},{"name":"Amount of oral contrast admin","type":"Preferred Question Text","description":"Amount of oral contrast administered","url":null,"context":"NCI Standards"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"99110E4F-B059-1E6A-E053-F662850A33D7","latestVersionIndicator":"Yes","beginDate":"2019-12-06","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-06","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"Created for CDISC aligned NCI Standard CRF task. ghd","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}